D930020B18Rik Inhibitors
The gene D930020B18Rik, expressed in the epididymis, olfactory epithelium, and vomeronasal organ, shares orthology with the human C12orf56 (chromosome 12 open reading frame 56). Exploring potential inhibitors for D930020B18Rik provides valuable insights into its functional roles, especially in the context of its tissue expression profile. While direct inhibitors for this gene may not be explicitly defined, several chemicals with known effects on cellular processes present intriguing options for indirect modulation. Tetrodotoxin, a potent sodium channel blocker, disrupts neural signaling by preventing action potentials. This may impact D930020B18Rik indirectly, influencing cellular processes associated with neuronal activity. Botulinum Toxin inhibits acetylcholine release, offering indirect modulation of D930020B18Rik's function by disrupting synaptic transmission and affecting neural signaling. Brefeldin A, an ADP-ribosylation factor (ARF) inhibitor, interferes with protein transport and vesicular trafficking. Its impact on intracellular trafficking may indirectly influence D930020B18Rik by altering cellular processes associated with protein localization and secretion.
Monensin disrupts ion gradients, potentially influencing D930020B18Rik by altering cellular processes associated with membrane potential and ion homeostasis. Castanospermine and Swainsonine, both affecting glycosylation processes, may modulate D930020B18Rik indirectly by impacting cellular processes associated with protein modification. Reserpine depletes monoamine storage, affecting neurotransmitter levels and potentially influencing D930020B18Rik by altering cellular processes associated with neural signaling and communication. Deoxynojirimycin, an alpha-glucosidase inhibitor, alters glycosylation processes and may influence D930020B18Rik by impacting cellular processes associated with protein modification. In summary, these chemicals offer diverse avenues for exploring the functional regulation of D930020B18Rik, providing insights into potential mechanisms of indirect modulation. Understanding the impact of these inhibitors on cellular processes associated with the gene's tissue expression may uncover novel aspects of its functional roles in specific physiological contexts.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Brefeldin A | 20350-15-6 | sc-200861C sc-200861 sc-200861A sc-200861B | 1 mg 5 mg 25 mg 100 mg | $31.00 $53.00 $124.00 $374.00 | 25 | |
An ADP-ribosylation factor (ARF) inhibitor, Brefeldin A disrupts protein transport and vesicular trafficking. Its impact on intracellular trafficking may influence D930020B18Rik indirectly by altering cellular processes associated with protein localization and secretion. | ||||||
Dantrolene | 7261-97-4 | sc-500165 | 25 mg | $350.00 | 7 | |
Dantrolene disrupts calcium release from the sarcoplasmic reticulum, potentially influencing cellular processes associated with D930020B18Rik by modulating intracellular calcium levels. Its indirect impact on signaling pathways may alter the protein's function in relevant cellular contexts. | ||||||
Guanethidine sulfate | 645-43-2 | sc-211570 | 1 g | $238.00 | 10 | |
Guanethidine inhibits the release of norepinephrine, impacting sympathetic neurotransmission. This indirect modulation may influence D930020B18Rik by altering cellular processes associated with neurotransmitter release and synaptic signaling. | ||||||
Tropicamide | 1508-75-4 | sc-202371 | 100 mg | $32.00 | 3 | |
Tropicamide inhibits muscarinic acetylcholine receptors, affecting neurotransmission. Its indirect impact on synaptic signaling may influence D930020B18Rik, altering cellular processes associated with neural communication. | ||||||
Monensin A | 17090-79-8 | sc-362032 sc-362032A | 5 mg 25 mg | $155.00 $525.00 | ||
Monensin disrupts ion gradients, potentially influencing D930020B18Rik by altering cellular processes associated with membrane potential and ion homeostasis. Its indirect impact on ion dynamics may modulate the protein's function in relevant cellular contexts. | ||||||
Castanospermine | 79831-76-8 | sc-201358 sc-201358A | 100 mg 500 mg | $184.00 $632.00 | 10 | |
An alpha-glucosidase inhibitor, Castanospermine alters glycosylation processes, potentially influencing D930020B18Rik by impacting cellular processes associated with protein modification. Its indirect impact on glycosylation may modulate the protein's function in relevant cellular contexts. | ||||||
Swainsonine | 72741-87-8 | sc-201362 sc-201362C sc-201362A sc-201362D sc-201362B | 1 mg 2 mg 5 mg 10 mg 25 mg | $138.00 $251.00 $631.00 $815.00 $1832.00 | 6 | |
Swainsonine inhibits alpha-mannosidase and alters glycosylation processes, potentially influencing D930020B18Rik by impacting cellular processes associated with protein modification. Its indirect impact on glycosylation may modulate the protein's function in relevant cellular contexts. | ||||||
Reserpine | 50-55-5 | sc-203370 sc-203370A | 1 g 5 g | $137.00 $414.00 | 1 | |
Reserpine depletes monoamine storage, affecting neurotransmitter levels. Its indirect modulation of neurotransmission may influence D930020B18Rik by altering cellular processes associated with neural signaling and communication. | ||||||
Deoxynojirimycin | 19130-96-2 | sc-201369 sc-201369A | 1 mg 5 mg | $73.00 $145.00 | ||
Deoxynojirimycin inhibits alpha-glucosidase, altering glycosylation processes and potentially influencing D930020B18Rik by impacting cellular processes associated with protein modification. Its indirect impact on glycosylation may modulate the protein's function in relevant cellular contexts. | ||||||